Navigation Links
Oxford Finance Corporation Hires Dr. Killu Sanborn to Support Life Science Business Development in Western North America
Date:9/8/2010

ALEXANDRIA, Va., Sept. 8 /PRNewswire/ -- Oxford Finance Corporation (Oxford), a subsidiary of Sumitomo Corporation, is pleased to announce the addition of Dr. Killu Sanborn to its Business Development group. As director, Business Development, she is responsible for originating loan facilities for life science companies, primarily in western North America.

She has over 20 years of experience as a lender and equity investor, banker, executive and entrepreneur. Her previous positions include managing director at Hercules Technology Growth Capital, senior vice president of Comerica Bank, principal/fund manager at IngleWood Ventures, director of Technology Commercialization at Stratagene and vice president of Business Development at Phenogenex. Over the years, Dr. Sanborn has also advised entrepreneurial boards and management teams on operational, financial and strategic matters.

"Dr. Sanborn is well-known and highly respected in the life science arena," said Christopher A. Herr, managing director for Oxford Finance Corporation. She brings with her a deep understanding of the financing needs of life science companies and will be a great asset to our Business Development team."

About Oxford Finance Corporation

A subsidiary of Sumitomo Corporation, Oxford is a specialty finance firm that provides senior secured loans to public and private life science and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated over $1.5 billion in loans, with lines of credit ranging from $500 thousand to $40 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.


'/>"/>
SOURCE Oxford Finance Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. ALS Therapy Development Institute and Oxford BioMedica Begin Second Phase of Collaboration to Develop Gene Therapies for Amyotrophic Lateral Sclerosis
2. Oxford BioTherapeutics Appoints Michael Moore as Chairman
3. Oxford Performance Materials Introduces OXPEKK PermettaTM High Performance Polymer Films
4. TED Conferences Announces 25 TED Fellows for TEDGlobal in Oxford
5. The Court Supports Bavarian Nordics Decision to Start Patent Infringement Case Against Oxford BioMedica
6. Bavarian Nordics Case Against Oxford BioMedica
7. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
8. Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller
9. Merrimack Pharmaceuticals Promotes William Sullivan to Vice President of Finance
10. Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement
11. Matan Companies Teams with Federal Capital Partners to Finance the National Cancer Institute at Riverside Research Park in Frederick, Maryland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... Princeton, NJ (PRWEB) , ... June 19, 2017 ... ... delivering innovative solutions for clinical development reported today that it is launching two ... Lake. The company will be demonstrating new capabilities at the DIA 2017 Annual ...
(Date:6/16/2017)... Boston, Massachusetts (PRWEB) , ... June 16, 2017 ... ... Big Data management and analytics solutions, today announced that its Anzo Smart Data ... Analytics and Semantic Technology Solution’ category for the 2017 Software & Information Industry ...
(Date:6/15/2017)... ... June 15, 2017 , ... The ... an artist’s journey through creative experimentation and interdisciplinary collaboration. Feature Creep, a solo ... 22nd. An opening reception will be held at EKG, located at 3600 Market ...
(Date:6/14/2017)... ... June 14, 2017 , ... ... discuss the initiative steered by the executive search firm, “Building Value in Precision ... Board of Directors of Foundation Medicine, led an open discussion with expert panelists ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):